TP53 and hepatocellular carcinoma: As known that, the p53 gene is mutated in approximately 50% of hepatoma cells [14], and the mutant p53 (mutp53) proteins not only lose their tumor suppressive activities but often gain additional oncogenic functions that endow cells with growth and survival advantages, differences in radio-sensitivity [15], [16].